Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice

Diabetes
Emil D BartelsLars B Nielsen

Abstract

Secondary hyperlipidemia is a major cardiovascular risk factor in individuals with type 2 diabetes. Increased hepatic production of apolipoprotein B (apoB)-containing lipoproteins contributes to the elevated plasma levels, but the mechanism is poorly understood. Recent results have established that microsomal triglyceride transfer protein (MTP) is rate limiting for the assembly and secretion of apoB-containing lipoproteins. To better understand the mechanism of type 2 diabetes-associated hyperlipidemia, we quantified hepatic MTP mRNA levels, hepatic microsomal triglyceride transfer activity, and in vivo triglyceride secretion from the liver in two diabetic mouse models. Obese diabetic (ob/ob) mice had 45% higher (P = 0.006) hepatic MTP mRNA levels, 54% higher (P < 0.0001) microsomal triglyceride transfer activity, and 70% higher (P < 0.0001) in vivo triglyceride secretion rates compared with ob/+ control mice. In contrast, in lean streptozotocin-treated diabetic mice, hepatic MTP mRNA levels were unchanged, whereas microsomal triglyceride transfer activity and in vivo triglyceride secretion rates were marginally decreased. These studies suggest that obesity-induced type 2 diabetes in mice confers increases in hepatic MTP expres...Continue Reading

References

Apr 1, 1987·Diabetes/metabolism Reviews·H N Ginsberg
Jan 1, 1984·Methods of Biochemical Analysis·J R Wetterau, D B Zilversmit
Jan 1, 1981·Diabetes·G M Reaven, M S Greenfield
Oct 1, 1994·Gastroenterology·B R BaconB A Neuschwander-Tetri
Jul 17, 1995·Biochemical and Biophysical Research Communications·A J BennettD A White
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·R V FareseS G Young
Apr 1, 1996·The Journal of Clinical Investigation·V V KunjathoorR C LeBoeuf
Aug 1, 1997·Diabetic Medicine : a Journal of the British Diabetic Association·S W Coppack
Nov 5, 1997·Diabetes Research and Clinical Practice·P ChouS T Tsai
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M RaabeS G Young
Mar 4, 1999·The Journal of Nutrition·M M VéniantS G Young
Apr 17, 1999·Molecular and Cellular Biology·M ForetzF Foufelle
Jul 27, 1999·The American Journal of Cardiology·B V Howard
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·M S Brown, J L Goldstein
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·I ShimomuraJ L Goldstein
Mar 14, 2000·The Journal of Biological Chemistry·G K LeungS G Young
Jul 13, 2000·The British Journal of Nutrition·J C Seidell
Jul 27, 2000·The Journal of Biological Chemistry·A H HastyN Yamada
Aug 1, 2000·The Journal of Biological Chemistry·G RothD Müller-Wieland

❮ Previous
Next ❯

Citations

Jun 1, 2013·Trends in Endocrinology and Metabolism : TEM·Mary E HaasSudha B Biddinger
Aug 19, 2007·Molecular BioSystems·Daniel A BlasioleAlan D Attie
Jan 28, 2010·The Journal of Biological Chemistry·Marcin KrzystanekLars Bo Nielsen
Oct 18, 2012·American Journal of Physiology. Endocrinology and Metabolism·Jennifer M RojasKevin D Niswender
May 24, 2008·The Journal of Clinical Investigation·Adama KamagateH Henry Dong
Apr 3, 2012·The Journal of Clinical Investigation·Ding AiAlan R Tall
Feb 23, 2005·Nutrition & Metabolism·Heather BascianoKhosrow Adeli
Apr 24, 2009·Journal of Lipid Research·Xiaoyue Pan, M Mahmood Hussain
Aug 3, 2011·Clinical Lipidology·M Mahmood HussainLisa Franceschini
Oct 19, 2004·European Journal of Gastroenterology & Hepatology·Dominique PessayreAbdellah Mansouri
May 16, 2012·The Journal of Physiology·Steen LarsenMartin Hey-Mogensen
May 28, 2011·Trends in Endocrinology and Metabolism : TEM·Sung Hee Choi, Henry N Ginsberg
Mar 2, 2010·Atherosclerosis·Bruno Vergès
May 27, 2008·Metabolism: Clinical and Experimental·Marie L S Lindegaard, Lars B Nielsen
May 26, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jiansheng HuangLi Wang
Sep 1, 2004·Journal of Hepatology·Nobuhiko TakahashiRexford S Ahima
Aug 29, 2006·Journal of Hepatology·Claudia Pinto Marques Souza de OliveiraFlair José Carrilho
Aug 21, 2015·Frontiers of Medicine·Lixia GanLiqing Yu
Nov 17, 2009·Biochemical and Biophysical Research Communications·Jie YuLan Huang
Jul 6, 2011·Annals of Medicine·Diego Perez-TilveSusanna M Hofmann
Mar 29, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Emil D BartelsLars B Nielsen
Jul 15, 2015·Cardiovascular Diabetology·Lene Nygaard AxelsenMorten Schak Nielsen
Jan 5, 2013·Journal of the American College of Cardiology·Steen LarsenFlemming Dela
Dec 18, 2013·Biochemical and Biophysical Research Communications·Lucas Martins FrançaAntonio Marcus de Andrade Paes
Dec 4, 2004·Journal of Lipid Research·Marie L S LindegaardLars B Nielsen
Sep 10, 2005·Journal of Lipid Research·Marie L S LindegaardLars B Nielsen
Apr 23, 2004·Journal of Lipid Research·Kirsten FaberLars Bo Nielsen
May 10, 2006·Journal of Lipid Research·Christina ChristoffersenBjörn Dahlbäck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.